Skye Bioscience, Inc. adopted Amendment No. 1 to their Amended and Restated 2014 Omnibus Incentive Plan, increasing the number of authorized shares of Common Stock and the aggregate number of shares that may be issued pursuant to the exercise of incentive stock options.